Clover Health tops Medicare Advantage ratings in NJ, GA, and SC for 2027, excelling in care continuity and prevention.

Clover Health earned top honors in U.S. News & World Report's 2027 Medicare Advantage ratings across New Jersey, Georgia, and South Carolina, recognized for best care continuity, overall quality, and screening & prevention. This reflects Clover's focus on preventive care and strong physician relationships, supported by its technology platform that aids clinical decisions. Clover's plans serve 5.2 million Medicare-eligible beneficiaries in 203 counties across five states, with enrollment open through December 7, 2026. The recognition underscores Clover's commitment to accessible, high-quality Medicare healthcare and its leadership in performance measures for non-SNP PPO plans.

As of Oct 20, 2026 03:42 WIB, Clover Health Investments Corp. Class A Common Stock (CLOV) trades at USD 4.45 on Pluang, down 0.67% for the day. The stock has a market cap of $2.38 billion and an enterprise value of $2.06 billion. This market data provides a snapshot of investor sentiment following Clover's recent recognition in U.S. News & World Report's 2027 Medicare Advantage ratings.